CANF CANF
Company Profile ↓Company Overview
CANF (CANF) is a publicly traded company listed on with a market capitalization of $8.38M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $405.00K (-39.9% YoY); net profit $-9.83M.
- Trailing 12 Months Year-on-year growth — revenue -39.9%.
- 5-Year Trend Long-term compounding — revenue CAGR -20.6%, profit CAGR 1.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -20.63% |
| 1 Year: | -39.91% |
Compounded Profit Growth
| 5 Years: | 1.13% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -76.81% |
| 6 Months: | -20.99% |
| 3 Months: | -8.57% |
| 1 Month: | -8.05% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)48.36 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -20.6% CAGR over 5 years.
- Trading 77.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 810.00K | 743.00K | 674.00K | 405.00K |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 10.91M | 8.94M | 8.80M | 10.36M |
| Operating Income | - | -10.10M | -8.20M | -8.13M | -9.95M |
| EBITDA | - | -10.08M | -8.18M | -8.12M | -9.93M |
| Interest Expense | - | - | - | - | - |
| Pretax Income | - | -10.17M | -7.63M | -7.88M | -9.83M |
| Tax Provision | 0 | 0 | 0 | - | - |
| Net Income | - | -10.17M | -7.63M | -7.88M | -9.83M |
| Diluted EPS | - | -60.00 | -32.26 | -19.55 | -10.75 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 9.28M | 9.99M | 9.12M | 9.51M |
| Current Assets | - | 9.16M | 9.91M | 8.98M | 9.44M |
| Cash & Equivalents | - | 2.98M | 4.28M | 4.83M | 5.53M |
| Inventory | - | - | - | - | - |
| Receivables | 48.00K | 47.00K | - | - | - |
| Total Liabilities | - | 4.81M | 3.75M | 3.68M | 3.92M |
| Current Liabilities | - | 2.50M | 2.02M | 2.05M | 2.73M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 62.00K | 40.00K | 104.00K | 71.00K |
| Total Equity | - | 4.47M | 6.24M | 5.44M | 5.59M |
| Shares Outstanding | - | 271.92K | 453.28K | 994.39K | 2.62M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -10.80M | -8.44M | -7.64M | -8.95M |
| Investing Cash Flow | - | 9.50M | 498.00K | 1.50M | -2.00K |
| Financing Cash Flow | - | 0 | 9.14M | 6.71M | 9.64M |
| Capital Expenditure | - | -9.00K | -2.00K | -5.00K | -2.00K |
| Free Cash Flow | - | -10.81M | -8.44M | -7.64M | -8.95M |
| Net Change in Cash | - | -1.30M | 1.20M | 569.00K | 693.00K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | -1,246.4% | -1,103.0% | -1,206.2% | -2,456.8% |
| Net Margin % | - | -1,255.9% | -1,027.5% | -1,169.1% | -2,426.7% |
| ROE % | - | -227.5% | -122.3% | -145.0% | -175.8% |
| ROCE % | - | -148.9% | -102.8% | -115.0% | -146.7% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Sabby Management, LLC | 1.99% | 42.56K | $136.19K |
| 2 | Citadel Advisors Llc | 1.59% | 34.15K | $109.28K |
| 3 | Rhumbline Advisers | 0.98% | 20.91K | $66.91K |
| 4 | HRT Financial LP | 0.90% | 19.38K | $62.02K |
| 5 | Virtu Financial LLC | 0.60% | 12.91K | $41.30K |
| 6 | Citigroup Inc. | 0.26% | 5.48K | $17.54K |
| 7 | UBS Group AG | 0.10% | 2.15K | $6.89K |
| 8 | Osaic Holdings Inc. | 0.02% | 450 | $1.44K |
| 9 | Fifth Third Bancorp | 0.01% | 150 | $480 |
| 10 | Wells Fargo & Company | 0.01% | 125 | $400 |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CANF
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE1FR3pPM3VFT1J4amlmSVZmYWVVMmktQVFDWW44X1BIMmlDeVlkc0xjLXNQNUVtcWJISG1xb1ZMRHVEcUFlZzNwdWhuMktYTEVv?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Pancreatic cancer patient alive 18+ months after second-line Namodenoson - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxObVRZTzBNYWtndlpFRnc5eW1WNUVKUlV2eG1wdXN0T1hPZFBDOERWcXQ5ZkdtbHNJVzdYY0ZfM2c2YnlpUzdBSEpPMlBzeG5zejVsRWJjUVlIbUdXUVpVSGJwc2tQd0RIaVhNZ2FBMFp4QnRUVFh3bHZMMDVvOWJuVGhsZ2xNZ1ZzaXpIdD…
Why Is CANF Stock Surging Today? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNOFpyOWo3VHd1bXp2QjR6SDBjS2p0S2FVek5qaFViZ3VwT1lHaVQ1RU9IM1pIa1dxX2NScVcyZnczV2t4d1BFbXZJWUpVb3R2UW5VN3JDMjNwcnUyTEMwY3ZhX2pnYUdVdFBlWG5ON1dvQjZJMVNZRWJ0OHNRMHZ4X1ZUTTQtbWpsLVoyUl…
CANF Looks 154.0% Overvalued on GF Value™ - GuruFocus
<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxPS3EtZGNHTjRFZFJQX0EtYXVwQVJ2RkpTQ2x1QzFGcGtXX0VQQTZ0YUFVelJtNXROcFkyOVFWVnZNWW81LWJSS0Npb2NIX3ZITlhGajBkd3Vad21JTXpGYlRGOVpiOVU2OExjdGZJTG45Uy1hOExDRFdJS2hCaVY0UFNaMA?oc=5" targe…
CANF Stock Pulls Back After Patent-Fueled Surge – Retail Calls It Consolidation Ahead Of Next Leg Up - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxOVVRFdFNmb2dkRk9QQV8xbVIxejY5S2JaLTdFYW1JckpNTG8zaDlpUW9pWHg3WjduTlQ4NS1STG1MVjFubzBWMTBQY2lLYUNndFFZYnZ3VGNMQ213VVJtLXdDaENzSlpUMVB2RUN3NGpVV0xtNzlFaGRuT2VYSnJjdVpRbWwyZ3cwd0tQWD…
CANF Stock Pops As Japan Patent Fuels Obesity-Drug Hype - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxORjVJek5MVnBiQy0yZXBGeldoWWQ3ZlVLbVh6TFgyMjdfWmhOZTJlaXFHbERfSnI5SEVIRS1Ja3RnWHhRZHE5M0Itam82d2xXeF8yV0k2R3MyNVFKcmRlZDAzUUlNQmF6UTJDY0kwNnBtSHpVdzdfWUF2b0tRN01uRw?oc=5" target="_…
CANF — Frequently Asked Questions
What is the current share price of CANF?
As of 2026-08-05 17:25 PDT, CANF trades at $3.20 on NASDAQ/NYSE. Its 52-week range is $2.75 to $14.00.
What is the market capitalisation of CANF?
CANF has a market capitalisation of $8.38M on NASDAQ/NYSE.
What is the P/E ratio of CANF?
CANF trades at a trailing price-to-earnings (P/E) ratio of -0.30. Its price-to-book (P/B) ratio is 1.50.
Is CANF a good stock to buy?
This page provides a data-driven analysis of CANF, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.